Never miss a story

Get subscribed to our newsletter


×
Vivo to open E-stores in India to increase its market. Wikimedia Commons

Chinese handset maker Vivo on Saturday launched the ‘Y17’ smartphone with a 5000mAh battery in India for Rs 17,990.

The phone comes with a triple rear AI camera (13MP+8MP+2MP sensors) and a 20MP selfie shooter. There’s a 16.15cm “FullView” display.


The device will be available in mineral blue and mystic purple variants across Flipkart, Amazon, Paytm, offline partner outlets and Vivo India e-store.


With an optical fingerprint sensor hidden beneath the display, V11Pro’s In-Display Fingerprint Scanning technology can accurately identify you. Eliminating the visible fingerprint pad results in a beautiful design, seamless from top to bottom, with effortless unlocking capabilities and a striking, futuristic feel.

“We are pleased to announce the latest addition to our Y-Series portfolio. The ‘Y17’ is packed with a range of innovative features that offer our consumers the latest technology at a competitive price,” Nipun Marya, Director Brand Strategy, Vivo India, said in a statement.

The ‘Y17’ runs on a MediaTek Helio P35 octa-core processor with a 12nm design and a clocking speed of up to 2.3GHz.

Also Read- Algeria Embarking ‘Clean Hands’ Campaign Against Corruption, Questions Tycoons

There’s 4GB RAM and 128GB ROM; the device runs Funtouch OS 9 based on Android 9.0. (IANS)


Popular

VOA

Bottles of Jack Daniel's whiskeys are displayed at Rossi's Deli in San Francisco

Jack Daniel's is the world's most popular whiskey brand, but until recently, few people knew the liquor was created by Nathan "Nearest" Green, an enslaved Black man who mentored Daniel.

"We've always known," says Debbie Staples, a great-great-granddaughter of Green's who heard the story from her grandmother. … "He made the whiskey, and he taught Jack Daniel. And people didn't believe it … it's hurtful. I don't know if it was because he was a Black man."

Keep Reading Show less
Photo by Aksh yadav on Unsplash

Cricket fans can now book the ultimate experience with the official accommodation booking partner for the ICC Men's T20 World Cup

Cricket fans can now book the ultimate experience with the official accommodation booking partner for the ICC Men's T20 World Cup, Booking.com. The T20 Pavillion, a bespoke cricket-themed luxury stay that transforms the Presidential Suite at Grand Hyatt Mumbai Hotel and Residences into a classic cricket stadium.


The suite offers guests an all-inclusive once-in-a-lifetime experience during the India vs Pakistan ICC Men's T20 World Cup match on October 24, 2021, packed with quirks and luxuries that is sure to satisfy even the biggest cricket enthusiast. Additionally, as a part of the experience, guests will also have the exclusive opportunity to meet Bollywood actor Shraddha Kapoor at The T20 Pavilion.

Keep Reading Show less
Photo by CDC on Unsplash

The findings from preliminary studies on possible stem cell-based Covid-19 treatments are frequently being exaggerated through press releases, social media and uncritical news media reports.

Amid the rush to find quick treatments for Covid-19 last year, the world saw a global race to find new stem cell-based treatments. Now, researchers report that such therapies were filled with violations of government regulations, inflated medical claims and distorted public communication. There are reports of patients suffering physical harm -- including blindness and death -- from unproven stem cell therapies.

"Efforts to rapidly develop therapeutic interventions should never occur at the expense of the ethical and scientific standards that are at the heart of responsible clinical research and innovation," said lead study author Laertis Ikonomou, associate professor of oral biology at University at Buffalo, New York. There are clinics offering unproven and unsafe "stem cell" therapies that promise to prevent Covid-19 by strengthening the immune system or improving overall health, the researchers noted in the paper published in the journal Stem Cell Reports.

Keep reading... Show less